about
Institutional shared resources and translational cancer researchFGFR1 amplification is associated with poor prognosis and smoking in non-small-cell lung cancer.Expression of HIF-1α in medullary thyroid cancer identifies a subgroup with poor prognosis.Approaching MALDI molecular imaging for clinical proteomic research: current state and fields of application.Robust automated tumour segmentation on histological and immunohistochemical tissue images.Extending the tissue microarray data exchange specification for inclusion of data analysis results.Glycoprotein analysis using protein microarrays and mass spectrometry.Time dependence of biomarkers: non-proportional effects of immunohistochemical panels predicting relapse risk in early breast cancer.Oncoproteomics: Trials and tribulations.Biomarkers of HIV-1-associated neurocognitive disorders: challenges of proteomic approachesTissue microarray construction for salivary gland tumors study.Tissue microarrays of human tumor xenografts: characterization of proteins involved in migration and angiogenesis for applications in the development of targeted anticancer agents.Innovations, challenges and future prospects of oncoproteomics.Expression and clinical value of EGFR in human meningiomas.The role of tissue microarray in the era of target-based agents.Protein microarray applications: Autoantibody detection and posttranslational modification.The expression of c-Met pathway components in unclassified pleomorphic sarcoma/malignant fibrous histiocytoma (UPS/MFH): a tissue microarray study.Next-generation tissue microarray (ngTMA) increases the quality of biomarker studies: an example using CD3, CD8, and CD45RO in the tumor microenvironment of six different solid tumor types.Tissue Microarray Technology for Molecular Applications: Investigation of Cross-Contamination between Tissue Samples Obtained from the Same Punching Device.Basal biomarkers nestin and INPP4b identify intrinsic subtypes accurately in breast cancers that are weakly positive for oestrogen receptor.P-cadherin expression as a prognostic biomarker in a 3992 case tissue microarray series of breast cancer.Statistical Methods for Tissue Array Images - Algorithmic Scoring and Co-training.The use of tissue microarrays for semiquantitative evaluation of ATPaseC1 expression is ineffective.Expression of insulin-like growth factor 2 in mesenchymal neoplasms.Targeting aggressive prostate cancer-associated CD44v6 using phage display selected peptides.A Benchmark for Comparing Precision Medicine Methods in Thyroid Cancer Diagnosis using Tissue Microarrays.Larger core size has superior technical and analytical accuracy in bladder tissue microarray.Nestin expression in breast cancer: association with prognosis and subtype on 3641 cases with long-term follow-up.Three-dimensional tumor model mimics stromal - breast cancer cells signaling.Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays.Analysis of cancer marker in tissues with Hadamard transform fluorescence spectral microscopic imaging.Clinical and prognostic value of MET gene copy number gain and chromosome 7 polysomy in primary colorectal cancer patients.HER3 protein expression in relation to HER2 positivity in patients with primary colorectal cancer: clinical relevance and prognostic value.Cytoplasmic YAP expression is associated with prolonged survival in patients with lung adenocarcinomas and epidermal growth factor receptor tyrosine kinase inhibitor treatment.The interplay between AR, EGF receptor and MMP-9 signaling pathways in invasive prostate cancer.
P2860
Q24288943-43F4B879-CF57-453A-9568-E6AD049ED91CQ27853055-439851EE-5821-4FFB-914E-02CA85499BB9Q33709832-0E95946C-47FE-4498-A690-D8FFF939FDAAQ33766329-9D6085DC-41FF-4573-831C-1020704A9A94Q33840806-101E6EAF-0CE0-47A3-A71C-97B95727E9B5Q33900060-93BA50D7-36C6-42AE-B6FE-2D7E74C68653Q33927735-D7278D53-BA75-4519-9886-C87A4C9E076BQ34687019-D55534BA-BC99-4F15-A621-C856511820CBQ35827653-2BA34D03-299E-4E69-A842-61CC291E8EA4Q36530897-9682ADE2-0517-4162-8679-B9A974838444Q36544198-A47479B8-4523-41E8-95E2-CAFCF77EDC44Q36870047-9EF89E9B-724D-4809-8237-2D1611CF6EC1Q37453835-0B820C39-1F6A-4991-B634-1D3E7AEBE374Q37732068-21FD639E-D8D3-4F32-BFBA-DF99AAD1FC82Q37894669-78099D35-D152-4404-AD30-F70ADBF21D5FQ38907014-386F39A2-86C7-4A88-9F99-233EDE00C83DQ39692688-CF1ED02F-CC54-4729-94FE-04277C1AE9F2Q40108069-D39A2835-815C-462C-80BD-732CF2E1E0D8Q40402965-DC795B4B-AF2C-43B8-BB33-4AE7D14A8172Q40656600-4571485C-D338-496E-8EB9-8520CCEE3493Q42477262-5ED14872-D5DA-4D4A-BD66-D1565DFE9756Q43073509-DFB3E9E2-44EF-4264-8895-CBAA97D483D2Q43332356-487205BF-9B99-4C05-94AA-F33B9EA467F3Q43887658-EB65E811-1D3B-424C-9DD3-A76EB9088398Q44262180-59E20948-90F7-415E-9DA5-382C6A82712AQ47205305-86C5FF73-0BA9-4836-BDCE-1D978F9EFD7FQ47241285-C7D6F209-A651-4648-A1E0-68CCB4F3602FQ48265721-8FE72DC4-66BA-4372-B922-71E8768432ABQ49319044-BBC53C87-0CB2-48CF-A639-C6E583D03114Q50790201-0EDD3974-C1C7-47E5-A204-A9AF1F5247C4Q53318118-E18D06C7-B6B8-4EC1-8961-EB7E2F26622BQ54260230-49ECE32E-87E8-4C84-ACC3-CD893A921D43Q54286661-CC246404-3F39-4588-A6FD-B17DE5C6330FQ54356882-41363044-D5DE-4608-A65F-C70FC3CF473BQ55425609-9928B380-892A-4347-AB0C-C7D18ED3079A
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Tissue microarrays in clinical oncology
@ast
Tissue microarrays in clinical oncology
@en
type
label
Tissue microarrays in clinical oncology
@ast
Tissue microarrays in clinical oncology
@en
prefLabel
Tissue microarrays in clinical oncology
@ast
Tissue microarrays in clinical oncology
@en
P2093
P2860
P1476
Tissue microarrays in clinical oncology
@en
P2093
Challayne Kenney
David Voduc
Torsten O Nielsen
P2860
P356
10.1016/J.SEMRADONC.2007.10.006
P577
2008-04-01T00:00:00Z